Umeclidinium bromide,
869113-09-7,
GSK573719A,
Umeclidinium (bromide),
Incruse Ellipta,
UNII-7AN603V4JV,
7AN603V4JV,
1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium Bromide,
GSK-573719,
1-(2-(benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-ium bromide,
CHEMBL523299,
Umeclidinium brom,
Umeclidinium bromide [USAN:INN],
umeclidinii bromidum,
umeclidinium-bromide,
1-Azoniabicyclo(2.2.2)octane, 4-(hydroxydiphenylmethyl)-1-(2-(phenylmethoxy)ethyl)-, bromide (1:1),
1-Azoniabicyclo[2.2.2]octane, 4-(hydroxydiphenylmethyl)-1-[2-(phenylmethoxy)ethyl]-, bromide (1:1),
Umeclidinium(bromide),
bromure d'umeclidinium,
bromuro de umeclidinio,
Incruse ellipta (TN),
4-[Hydroxy(diphenyl)methyl]-1-{2-[(phenylmethyl)oxy]ethyl}-1-azoniabicyclo[2.2.2]octane Bromide,
SCHEMBL109931,
CHEBI:79040,
DTXSID50235966,
PEJHHXHHNGORMP-UHFFFAOYSA-M,
Umeclidinium bromide (JAN/USAN),
BCP11148,
EX-A1683,
GSK-573719A,
KS-00001CW3,
Umeclidinium bromide(GSK573719A),
AKOS025404842,
CS-0874,
SB16738,
VA12030,
AK174796,
HY-12100,
SY226333,
MFCD27976798 (95%),
D10181,
1-(2-(Benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)-1-azoniabicyclo(2.2.2)octane bromide,
1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane bromide,
diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide,
D09ZOQ,
Umeclidinium bromide [USAN],
Umeclidinium(GSK573719A),
ACN-041384,
CID11519069,
A3900,
A15268,
Diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]oct-4-yl]methanol Bromide,